Related Experiment Videos
Economic endpoints in clinical trials
1Department of Health Research and Policy, Department of Medicine, Stanford University School of Medicine, HRP Redwood Building, Room 150, Stanford, CA 94305-5405, USA. hlatky@stanford.edu
Epidemiologic Reviews
|July 18, 2002
Summary
Economic endpoints in clinical trials are growing. Research is refining methods for measuring and analyzing cost data to meet public demand for efficient healthcare.
Area of Science:
- Health Economics
- Clinical Trial Methodology
Background:
- Economic endpoints are increasingly incorporated into randomized clinical trials.
- The methodologies for measuring and analyzing healthcare costs are still developing within this field.
Purpose of the Study:
- To highlight the evolving nature of economic endpoint analysis in clinical trials.
- To underscore the impact of public demand on the advancement of health economic methods.
Main Methods:
- Analysis of trends in economic endpoint inclusion in clinical trials.
- Review of current and emerging methods for cost data measurement and analysis.
Main Results:
- Economic endpoints represent a growing area within clinical trial research.
- The field requires further methodological development to meet research and public demands.
Conclusions:
- Advancements in economic endpoint analysis are crucial for demonstrating the value of medical interventions.
- Clinical trial findings integrating economic data will increasingly inform public health policy and resource allocation.